Please login to the form below

Not currently logged in

FDA approves new version of diabetes drug

Japanese pharmaceutical company Daiichi Sankyo's diabetes treatment Welchol has been approved in a new formulation by the US Food and Drug Administration

Japanese pharmaceutical company Daiichi Sankyo has received US Food and Drug Administration (FDA) approval for a new formulation of its liquid diabetes drug Welchol that can be mixed with fruit juice and diet sodas.

Welchol was first approved in 2009 and was to be mixed with water. The drug lowers blood sugar in patients diagnosed with type 2 diabetes.

Meanwhile Daiichi Sankyo is replacing its legacy, on-premise customer relationship management (CRM) system with Veeva CRM in the UK. The company will deploy Veeva CRM to all of its commercial teams in the UK.

Cloud-based, Veeva CRM requires no hardware or software to purchase, scale or maintain. In addition, Veeva customers benefit from free, automatic upgrades. Changes can be made to the system without user retraining or additional third-party costs.

26th July 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...